MedTrace Logo

Use of Arimidex and Zoladex as Pretreatment to IVF in Women With Ovarian Endometriosis

NCT00286351 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2007-04-23

No results posted yet for this study

Summary

Does a combination of Arimidex and Zoladex make endometriomas shrink and how is the following IVF outcome

Conditions

  • Endometriosis

Interventions

DRUG

Combined treatment with Arimidex and Zoladex before IVF

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Kristine Lossl, medical doctor · The Fertility Clinic, Copenhagen University Hospital Rigshospitalet

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00286351 on ClinicalTrials.gov